Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors
- PMID: 28542088
- DOI: 10.1097/ICO.0000000000001231
Corneal Breakthrough Haze After Photorefractive Keratectomy With Mitomycin C: Incidence and Risk Factors
Abstract
Purpose: To identify preoperative and intraoperative factors affecting breakthrough corneal haze incidence after photorefractive keratectomy (PRK) with mitomycin C (MMC).
Methods: In this retrospective study of PRK performed at the Care Vision Refractive Laser Center, Tel Aviv, Israel, a total of 7535 eyes (n = 3854 patients; mean age ± SD, 26 ± 6 years; 55% men) underwent PRK with intraoperative MMC application. Patients with histories of corneal pathology or surgery were excluded. Incidence, time of onset, and corneal haze severity were documented on follow-up of 118 ± 110 days. Eyes were grouped by preoperative refraction [low (≤-3D), moderate (-3D to -6D), or high (>-6D) myopia; low (≤3D) or high (>3D) astigmatism; low or high hyperopia]; by intraoperative time (above or below 40 seconds); and by MMC application time (above or below 40 seconds). The main outcome measures were incidence, onset time, and severity of corneal haze.
Results: The haze incidence was 2.1% in eyes with high myopia versus 1.1% in those with low to moderate myopia (P = 0.002), and 3.5 times higher in eyes with high than with low astigmatism (P < 0.05). The overall incidence was higher in eyes treated for hyperopia (10.8%) than for myopia (1.3%) (P = 0.0001). In eyes with moderate myopia, the haze incidence was lower in MMC application time ≥40 seconds (0%) than in <40 seconds (1.3%) (P = 0.03). After surgery, a mild early haze incidence peaked at 68.8 ± 6 days and severe late haze at 115 ± 17 days (P = 0.02).
Conclusions: Hyperopic and large myopic or astigmatic corrections carry higher risk of haze. Longer MMC application might have beneficial haze prevention.
Similar articles
-
Comparison of Single-Step Transepithelial Photorefractive Keratectomy With or Without Mitomycin C in Mild to Moderate Myopia.J Refract Surg. 2018 Jun 1;34(6):400-407. doi: 10.3928/1081597X-20180402-02. J Refract Surg. 2018. PMID: 29889293
-
Randomized dose-response analysis of mitomycin-C to prevent haze after photorefractive keratectomy for high myopia.J Cataract Refract Surg. 2013 Sep;39(9):1358-65. doi: 10.1016/j.jcrs.2013.03.029. Epub 2013 Jul 3. J Cataract Refract Surg. 2013. PMID: 23830559 Clinical Trial.
-
Reduced application time for prophylactic mitomycin C in photorefractive keratectomy.Ophthalmology. 2010 May;117(5):885-9. doi: 10.1016/j.ophtha.2009.10.024. Epub 2010 Feb 16. Ophthalmology. 2010. PMID: 20163867
-
Biological effects of mitomycin C on late corneal haze stromal fibrosis following PRK.Exp Eye Res. 2020 Nov;200:108218. doi: 10.1016/j.exer.2020.108218. Epub 2020 Sep 6. Exp Eye Res. 2020. PMID: 32905844 Free PMC article. Review.
-
Mitomycin C for the prevention of corneal haze in photorefractive keratectomy: a meta-analysis and trial sequential analysis.Acta Ophthalmol. 2021 Sep;99(6):652-662. doi: 10.1111/aos.14704. Epub 2020 Dec 16. Acta Ophthalmol. 2021. PMID: 33326173
Cited by
-
Main Complications of Photorefractive Keratectomy and their Management.Clin Ophthalmol. 2019 Nov 27;13:2305-2315. doi: 10.2147/OPTH.S233125. eCollection 2019. Clin Ophthalmol. 2019. PMID: 31819355 Free PMC article. Review.
-
Blocking Mitochondrial Pyruvate Transport Alters Corneal Myofibroblast Phenotype: A New Target for Treating Fibrosis.Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):36. doi: 10.1167/iovs.64.13.36. Invest Ophthalmol Vis Sci. 2023. PMID: 37870848 Free PMC article.
-
Photorefractive keratectomy (PRK) Prediction, Examination, tReatment, Follow-up, Evaluation, Chronic Treatment (PERFECT) protocol - A new algorithmic approach for managing post PRK haze.Indian J Ophthalmol. 2020 Dec;68(12):2950-2955. doi: 10.4103/ijo.IJO_2623_20. Indian J Ophthalmol. 2020. PMID: 33229676 Free PMC article.
-
Bowman's layer transplantation: evidence to date.Clin Ophthalmol. 2018 Mar 5;12:433-437. doi: 10.2147/OPTH.S141127. eCollection 2018. Clin Ophthalmol. 2018. PMID: 29551887 Free PMC article. Review.
-
LASIK versus PRK for high astigmatism.Int Ophthalmol. 2021 Jun;41(6):2091-2098. doi: 10.1007/s10792-021-01766-5. Epub 2021 Mar 22. Int Ophthalmol. 2021. PMID: 33751303
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources